Global Liver Institute
News
GLOBAL LIVER INSTITUTE
Global Liver Institute’s Response to FDA Briefing on NASH Drug Development
(Washington, D.C., January 29, 2021) Thank you to the Food and Drug Administration (FDA) for the informative briefing earlier today titled, “Regulatory Perspectives for Development of Drugs for Treatment of NASH.” We appreciate that the FDA has followed through on our 2020…
Global Liver Institute’s Response to Washington, DC, Vaccine Distribution Strategy
(Washington, D.C., January 25, 2021) On January 21, DC Health announced the plan to open up vaccine access, possibly as soon as February, to an expansive population including habitual smokers or anyone with a body mass index over 25…
Global Liver Institute Announces 2021 Board of Directors
(Washington, D.C., January 14, 2021) In 2020, Global Liver Institute (GLI), whose mission is to improve the lives of individuals and families impacted by liver disease through promoting innovation, encouraging collaboration, and supporting the scaling of optimal approaches to help eradicate…
GLI Submits Letter to President-elect Biden on the 2021 Liver Health Policy Priorities
(Washington, D.C., January 8, 2021) In 2020, Global Liver Institute (GLI) observed increases in the prevalence of liver diseases and mortality associated with it. These developments are established trends which GLI seeks to reverse. These trends, however, were accelerated directly and indirectly…
GLI Applauds Introduction of the COVID-19 Prevention and Awareness Act (CPAA)
(Washington, D.C., January 6, 2021) Global Liver Institute (GLI) applauds the leadership of Congresswoman Nydia Velázquez (D-NY) in introducing the COVID-19 Prevention and Awareness Act (CPAA). The current COVID-19 pandemic is putting unprecedented pressure on our nation’s health care system, including by disproportionately impacting people with certain underlying medical conditions like liver disease…
January 2021 Welcome Message : Unbound, and yet, Connected
As we reassess, reset, and reengage in our work with and for people, families, and communities around the world at-risk for and living with liver conditions I wanted to take moment to share what I believe are the two most resonant lessons for us from 2020 shaping 2021.
Global Liver Institute Releases Comprehensive U.S. NASH Action Plan
(Washington, D.C., December 18, 2020) – Today, Global Liver Institute (GLI) and the GLI NASH Council released the U.S. NASH Action Plan to comprehensively address nonalcoholic steatohepatitis (NASH), the advanced form of nonalcoholic fatty liver disease (NAFLD), and its impact on patients…
Holiday Message to All Our Friends in the Liver Community
Throughout the pandemic and the transition to a fully virtual work environment, we learned to look within ourselves and to those we could count on, our community. We relied on the dedication, creativity, and agility of our team and those supporting us and cheering us on. We stayed focused on our goal to improve the lives of the half a billion people around the world…
CALL TO ACTION: Request for Advocates to Urge Members of Congress to Sign Bi-Partisan Letter Requesting that HHS Secretary Azar Finalize OPO Rules
The U.S. Department of Health and Human Services (HHS) has proposed organ procurement organization (OPO) reforms that will help thousands more patients access organ transplants. We have a time-sensitive ask for Members of Congress to sign on to a letter requesting that HHS…
Bipartisan reform of organ procurement organizations (OPOs) will save lives
Summary: HHS has proposed OPO reforms that will help thousands more patients access organ transplants. Misleading claims should not stop this lifesaving, bipartisan effort. Answers to new AOPO points below. The Global Liver Institute has highlighted previous misleading claims. Former HHS Chief Technology Officer Bryan Sivak called OPOs…
Caregiving During COVID-19
Here at GLI, we understand the vital role that caregivers/carepartners play in the lives of liver patients. Caregivers are more important than ever during the COVID-19 pandemic, but it has brought new challenges when navigating the medical system. This GLI update, and our recent GLI LIVE episode on “Caregiving During COVID” with Dr. Donnica Moore, explores…
Disparities in the Spread of and Response to COVID-19
Although all humans appear susceptible to infection by the COVID-19 virus, some communities and some racial and ethnic groups are infected, experience greater illness, and are hospitalized at rates higher than other groups, and are more likely to die. The disparities in infection, illness, and death are not just based on race or ethnicity, but may also be related…